- Home
- RADX vs PCLA Comparison
RADX vs PCLA Comparison
Compare RADX & PCLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RADX
- PCLA
- Stock Information
- Founded
- RADX 2021
- PCLA 2008
- Country
- RADX Australia
- PCLA Japan
- Employees
- RADX N/A
- PCLA N/A
- Industry
- RADX
- PCLA Building Products
- Sector
- RADX
- PCLA Consumer Discretionary
- Exchange
- RADX NYSE
- PCLA Nasdaq
- Market Cap
- RADX 32.5M
- PCLA 32.3M
- IPO Year
- RADX N/A
- PCLA 2025
- Fundamental
- Price
- RADX $4.17
- PCLA $2.50
- Analyst Decision
- RADX Strong Buy
- PCLA
- Analyst Count
- RADX 2
- PCLA 0
- Target Price
- RADX $13.50
- PCLA N/A
- AVG Volume (30 Days)
- RADX 22.6K
- PCLA 2.3M
- Earning Date
- RADX 02-26-2025
- PCLA 01-01-0001
- Dividend Yield
- RADX N/A
- PCLA N/A
- EPS Growth
- RADX N/A
- PCLA N/A
- EPS
- RADX N/A
- PCLA N/A
- Revenue
- RADX $204,609.00
- PCLA $5,475,228.00
- Revenue This Year
- RADX N/A
- PCLA N/A
- Revenue Next Year
- RADX N/A
- PCLA N/A
- P/E Ratio
- RADX N/A
- PCLA N/A
- Revenue Growth
- RADX N/A
- PCLA 40.19
- 52 Week Low
- RADX $3.50
- PCLA $0.37
- 52 Week High
- RADX $50.82
- PCLA $9.80
- Technical
- Relative Strength Index (RSI)
- RADX N/A
- PCLA N/A
- Support Level
- RADX N/A
- PCLA N/A
- Resistance Level
- RADX N/A
- PCLA N/A
- Average True Range (ATR)
- RADX 0.00
- PCLA 0.00
- MACD
- RADX 0.00
- PCLA 0.00
- Stochastic Oscillator
- RADX 0.00
- PCLA 0.00
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.
About PCLA PicoCELA Inc. American Depositary Shares
PicoCELA Inc specializes in manufacturing, installing, and servicing enterprise wireless mesh solutions. The company generates revenue from two main sources: product equipment sales, and Software as a Service (SaaS) and maintenance services. The company develops the PCWL series of mesh Wi-Fi access points, which utilize its proprietary PicoCELA Backhaul Engine (PBE) technology to enable wireless communication. The company outsources manufacturing and sells these devices directly to customers through distributors. Additionally, the company offers a cloud portal service in a SaaS model, allowing users to monitor connectivity and traffic at their access points. This platform also supports the installation of proprietary edge-computing software into the devices.